FilingFirehose · free AI preview
Liminatus Pharma, Inc.
LIMN · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Delisting
Liminatus Pharma (LIMN) filed a delisting notice on May 27, 2026, marking a critical corporate event within our 90-day window. This single red flag raises immediate questions about the company's exchange compliance status, capital structure, and shareholder dilution exposure. Our real-time pipeline detected zero cyber incidents, but the delisting filing demands deeper context. The full $49 Report adds delisting-risk timeline analysis, 12-month financing history, dilution metrics, and AI-scored warning signals across regulatory, operational, and market-structure dimensions.
Want the full 5-section $49 Report on LIMN?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.